Cardiopulmonary is a unique and challenging area of development, with the majority of cardiopulmonary-related indications encompassing complex and critically ill patient populations. The CTI team includes experienced regulatory and clinical operations personnel who understand the complex and interdependent characteristics of cardiac research. Our familiarity with these unique challenges and interventional treatment experience allows us to efficiently execute these projects. We attend industry meetings and are members of many cardiopulmonary societies, including the International Society for Heart and Lung Transplantation (ISHLT).